Is Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd.'s patent grant rate increasing or decreasing?

Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd.'s recent grant velocity is -25% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd.

Q: Where does Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd. ranks #27,827 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Q: How is the Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 10 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Wilmar ranks #27,827 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 18 technology areas.

#27,827
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.0/100): 15.0
avg claims per patent: -25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R27827 · Foreign Corporation #27,827 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #27,827/49,997
PHOTO-FINISH Westrock Slatersville
CPC-FOCUS C12N · 18 areas
INNOV-THIN 39.0/100
CLAIMS-RICH 15.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Westrock Slatersville, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Wilmar’s 39.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (21%) Velocity 6.7 pts (17%) Breadth 15.0 pts (38%) Claim depth 9.0 pts (23%)

Qualcomm Incorporated · highest

85
Wilmar (SHANGHAI)… · this assignee

39
3D Lighting… · lowest

7

What this shows Wilmar's Innovation Score is 39.0/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Wilmar?

Each dot is one of Wilmar’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Wilmar’s own 15.0 claims/patent is ABOVE the 7.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Wilmar vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Wilmar's grants concentrate

Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd. is a focused PatentsView assignee: 18 CPC subclasses with 70% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2015. By volume, Wilmar sits between Westrock Slatersville, LLC and Wuhan Lotus Cars Co., Ltd.

Wilmar's three-year grant acceleration

Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd. shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Westrock Slatersv…

10
Wexenergy

10
WG Security Produ…

10
Wilden Pump AND E…

10
Woom

10
Wooshin Industries

10
Wuhan Institute O…

10
Wuhan Lotus Cars

10
Wilmar (Shanghai)… ◀

10

What this shows Wilmar holds 10 patents at rank #27,807, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Wilmar

By rank, the assignees closest to #27,807 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Wilmar's primary technology class.

Wilmar's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	10.0%
2018	2	20.0%
2019	1	10.0%
2020	1	10.0%
2023	2	20.0%
2025partial year	3	30.0%

Which technologies does Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 7

C12Y - Enzymes 7

C11B - Producing, e.g. BY Pressing RAW Materials OR BY Extraction From Waste Materials, Refining OR Preserving Fats, Fatty Substances, e.g. Lanolin, Fatty Oils OR WAXES; Essential OILS; Perfumes 6

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 5

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 3

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 3

C07K - Peptides 2

C11C - Fatty Acids From Fats, Oils OR WAXES; CANDLES; Fats, Oils OR Fatty Acids BY Chemical Modification OF Fats, Oils, OR Fatty Acids Obtained Therefrom 2

A23K - Fodder 2

A23P - Shaping OR Working OF Foodstuffs, NOT Fully Covered BY A Single Other Subclass 1

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

C07C - Acyclic OR Carbocyclic Compounds 1

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 1

A21D - Treatment OF Flour OR Dough FOR Baking, e.g. BY Addition OF MATERIALS; BAKING; Bakery Products 1

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd.'s patent record in context - here's where to go next.

Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 70% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #27,827 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd. against Westrock Slatersville, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.